Tracer library / [64Cu]Pep-1L

[64Cu]Pep-1L

Also written as [Cu-64]Pep-1L
Radionuclide
Cu-64 t½ 762 min
Modality
PET
Production route
—
Stage
Preclinical
Syntheses indexed
1

What it is

Compound class
NOTA-conjugated peptide (IL13RA2-targeted peptide, Pep-1L)
Target / mechanism
IL13RA2 (interleukin 13 receptor alpha 2) targeted peptide PMID 28562337
Clinical application
Glioblastoma (GBM) PMID 28562337
Theranostic pair
[225Ac]Ac-Pep-1L

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
Manual synthesis———>98%NOTA-Pep-1L
CPC Scientific, San Jose, CA
28562337
2017 Oncotarget
Both the peptides, Pep-1L and scrambled peptide-NOTA were radiolabeled with Cu-64 according to the previously reported methods

Precursor

Common precursor
—
Suppliers seen in the literature
—
Cited suppliers in indexed syntheses
CPC Scientific
Typical final purification
—

Need this precursor?We can point you to suppliers for [64Cu]Pep-1L, or handle the enquiry for you.

Get in touch

Notes

Added at stage 22: promoted from 'Reported once' (single-article, no diagnostic pair at discovery) because a full-text synthesis with extracted data exists in parsed-therapy.xlsx -- PMID(s): 28562337. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty. Compound class inferred from precursor name (not stated outright) -- PMID 28562337: 'NOTA-Pep-1L'. | Stage 30 (2026-09-18): Modality was 'Therapy' -- a bucket value given to every agent found by the therapy-oriented bulk search (stages 21-22), not a source statement. Corrected to PET: Cu-64 agent whose theranostic partner ac225-pep1l carries the therapy isotope Ac-225: this is the imaging half of the pair. Linked articles: PMID 28562337. Stage set/updated at stage 39 from PMID 28562337: 'we demonstrated real-time GBM localization of [64Cu]Pep-1L to orthotopic GBMs using small animal PET imaging'.
Ask a question